XML 76 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Investments:    
Fixed maturities available-for-sale, at fair value (amortized cost: $212.9 million and $208.3 million, respectively) $ 212.2 $ 205.7
Short-term investments, at fair value (amortized cost: $175.4 million and $167.6 million, respectively) 175.4 167.6
Total investments 387.6 373.3
Cash and cash equivalents 140.9 197.6
Restricted cash 39.3 35.2
Accounts receivable, net of allowance of $0.5 million and $0.6 million, respectively 172.8 167.0
Reinsurance recoverable on paid and unpaid losses and LAE 326.0 285.3
Prepaid reinsurance premiums 249.3 274.2
Ceding commissions receivable 85.7 79.5
Capitalized internal use software 47.4 48.1
Intangible assets 16.1 17.0
Other assets 75.3 66.2
Total assets 1,540.4 1,543.4
Liabilities:    
Loss and loss adjustment expense reserve 400.8 350.0
Unearned premiums 446.0 457.9
Reinsurance premiums payable 238.3 248.6
Provision for commission 38.7 34.3
Accrued expenses and other liabilities 90.9 87.4
Total liabilities 1,214.7 1,178.2
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Common stock, $0.0001 par value per share; 80,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 25,157,214 and 24,866,803 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 0.0 0.0
Additional paid-in capital 1,646.0 1,639.7
Accumulated other comprehensive loss (0.6) (2.7)
Accumulated deficit (1,322.6) (1,274.9)
Total Hippo stockholders’ equity 322.8 362.1
Noncontrolling interest 2.9 3.1
Total stockholders’ equity 325.7 365.2
Total liabilities and stockholders’ equity $ 1,540.4 $ 1,543.4